Page last updated: 2024-09-03

ly 134046 and angiotensin ii

ly 134046 has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(ly 134046)
Trials
(ly 134046)
Recent Studies (post-2010)
(ly 134046)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
310038,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomyly 134046 (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganong, WF; Steele, MK1

Other Studies

1 other study(ies) available for ly 134046 and angiotensin ii

ArticleYear
Effects of catecholamine-depleting agents and receptor blockers on basal and angiotensin II- or norepinephrine-stimulated luteinizing hormone release in female rats.
    Endocrinology, 1986, Volume: 119, Issue:6

    Topics: Angiotensin II; Animals; Benzazepines; Catecholamines; Ditiocarb; Dopamine beta-Hydroxylase; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Ovariectomy; Phenylethanolamine N-Methyltransferase; Prazosin; Propranolol; Rats; Saralasin; Yohimbine

1986